Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Cyteph Completes Recruitment for Phase I Clinical Trial of CYT-101 in Patients with Recurrent Glioblastoma Multiforme Brain Cancer

Summary by Charleston Gazette-Mail
BRISBANE, Australia, Oct. 7, 2025 /PRNewswire/ -- Cyteph Pty Ltd, a biotechnology company developing novel immunotherapies for difficult-to-treat cancers, today announced that it has successfully completed recruitment for its first-in-human Phase I clinical trial of CYT-101.

52 Articles

The Manila TimesThe Manila Times
Lean Right

Cyteph Completes Recruitment for Phase I Clinical Trial of CYT - 101 in Patients with Recurrent Glioblastoma Multiforme Brain Cancer

·Manila, Philippines
Read Full Article
Fox 4 Kansas CityFox 4 Kansas City
+50 Reposted by 50 other sources
Center

Cyteph Completes Recruitment for Phase I Clinical Trial of CYT-101 in Patients with Recurrent Glioblastoma Multiforme Brain Cancer

·Kansas City, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 72% of the sources are Center
72% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Fox 4 Kansas City broke the news in Kansas City, United States on Tuesday, October 7, 2025.
Sources are mostly out of (0)

Similar News Topics

Brisbane City icon

Brisbane City

News
For You
SearchBlindspotLocal